These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6734405)

  • 1. Effects of biguanides and sulfonylureas on insulin receptors in cultured cells.
    Goldfine ID; Iwamoto Y; Pezzino V; Trischitta V; Purrello F; Vigneri R
    Diabetes Care; 1984; 7 Suppl 1():54-8. PubMed ID: 6734405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells.
    Vigneri R; Pezzino V; Wong KY; Goldfine ID
    J Clin Endocrinol Metab; 1982 Jan; 54(1):95-100. PubMed ID: 7033271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells.
    De Vries CP; van der Veen EA
    Diabetes Res; 1986 Jul; 3(6):307-10. PubMed ID: 3757414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
    Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
    Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sulfonylureas and clofibrate on insulin receptors in cultured human lymphocytes.
    Zeng SF; Yokono K; Baba S
    Kobe J Med Sci; 1985 Aug; 31(4):169-82. PubMed ID: 3906258
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulfonylurea effects on target tissues for insulin.
    McCaleb ML; Maloff BL; Nowak SM; Lockwood DH
    Diabetes Care; 1984; 7 Suppl 1():42-6. PubMed ID: 6376028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and insulin receptors.
    Vigneri R; Gullo D; Pezzino V
    Diabetes Care; 1984; 7 Suppl 1():113-7. PubMed ID: 6376023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors.
    Prince MJ; Olefsky JM
    J Clin Invest; 1980 Sep; 66(3):608-11. PubMed ID: 6772676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6.
    Sawada F; Inoguchi T; Tsubouchi H; Sasaki S; Fujii M; Maeda Y; Morinaga H; Nomura M; Kobayashi K; Takayanagi R
    Metabolism; 2008 Aug; 57(8):1038-45. PubMed ID: 18640379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin resistance in type 2 diabetes. Receptor and post-receptor aspects].
    Purrello F; Trischitta V; Vigneri R
    Minerva Endocrinol; 1984; 9(2):221-8. PubMed ID: 6390135
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative activity of some biguanides, sulfonylureas and their combinations on blood sugar and lactic acid in the guinea pig. II].
    Bramanti G; Bianchini P; De Fina V; Dell'Omodarme G
    Boll Chim Farm; 1971 Apr; 110(4):226-36. PubMed ID: 5111348
    [No Abstract]   [Full Text] [Related]  

  • 12. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of oral hypoglycemic agents.
    Hagg SA
    Am J Hosp Pharm; 1976 Sep; 33(9):943-7. PubMed ID: 790951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides.
    Mannucci E; Monami M; Masotti G; Marchionni N
    Diabetes Metab Res Rev; 2004; 20(1):44-7. PubMed ID: 14737744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of oral hypoglycemic agents in the therapeutic approach to diabetic obesity].
    Albert J; Ekoé JM
    Sem Hop; 1983 Sep; 59(29-30):2135-40. PubMed ID: 6312587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral antidiabetic drugs on lipase activity in vitro.
    Holmes JH; Sapeika N; Zwarenstein H
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):667-70. PubMed ID: 1179037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of phenformin and other adenosine triphosphate (ATP)-lowering agents on insulin binding to IM-9 human cultured lymphocytes.
    Vigneri R; Maddux B; Goldfine ID
    J Cell Biochem; 1984; 24(2):177-86. PubMed ID: 6327744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
    Losert W; Hoder A; Scholz C
    Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
    Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.